Allied Biotech Corp(TW:1780)
NT$23.70-0.10 (-0.21%)
TW:1780
Allied Biotech Corp Revenue
NT$23.70
At close:-0.10 (-0.21%)
Allied Biotech Corp (1780) Revenue
Allied Biotech Corp Revenue
Allied Biotech Corp had a revenue of 498.40M in the quarter ending Jun 30, 2026, with 19.21%. This bring the company's revenue in the last twelve months to 916.48M, Increased 7.88%. In the fiscal year ending Dec 31, 2025, Allied Biotech Corp had annual revenue of 849.51M with 5.28% growth.
- Revenue (ttm)
- 916.48M
- Revenue Growth
- ―
- P/S Ratio
- 3.04
- Revenue/Employee
- TWD 21,237,675
- Employees
- 40
- Market Cap
- TWD 2.59B
Revenue Chart
Allied Biotech Corp Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 849.51M | 42.59M | 5.28% |
| Dec 31, 2024 | 806.92M | 86.49M | 12.00% |
| Dec 31, 2023 | 720.43M | 3.69M | 0.51% |
| Dec 31, 2022 | 716.75M | 39.99M | 5.91% |
| Dec 31, 2021 | 676.76M | 58.69M | 9.50% |
| Dec 31, 2020 | 618.07M | -21.33M | -3.34% |
| Dec 31, 2019 | 639.39M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.